Could 1 Tiny Biotech Topple Vertex Pharmaceuticals' Cystic Fibrosis Empire?

Summary

Article speculates on whether small biotech company Sion Therapeutics could challenge Vertex Pharmaceuticals' dominance in the cystic fibrosis market. The headline presents a comparative analysis with no specific clinical, regulatory, or financial details provided.